Bora CDMO Bora CDMO

X

Find Radio Compass News for Ibritumomab Tiuxetan

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

https://www.prnewswire.com/news-releases/casi-pharmaceuticals-to-present-at-the-jefferies-2020-healthcare-conference-301068743.html

PRNEWSWIRE
02 Jun 2020

https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-launch-of-evomela-melphalan-for-injection-in-china-300899773.html

PR NEWSWIRE
12 Aug 2019

https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-china-national-medical-products-administration-nmpa-approval-of-cta-to-conduct-confirmatory-clinical-trial-for-zevalin-300797617.html

PR NEWSWIRE
19 Feb 2019

https://www.pharmaceutical-technology.com/news/deals-and-mas-this-week-alnylam-pharmaceuticals-novartis/

PHARMA TECH
25 Jan 2019

https://medcitynews.com/2019/01/spectrum-pharmaceuticals-sells-marketed-drugs-to-aurobindo-subsidiary-for-up-to-300m/?rf=1

Alaric Dearment MEDCITY NEWS
18 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019

FDA
12 Dec 2018
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY